L
Linda Fried
Researcher at University of Pittsburgh
Publications - 59
Citations - 9383
Linda Fried is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Kidney disease & Peritoneal dialysis. The author has an hindex of 33, co-authored 59 publications receiving 8478 citations. Previous affiliations of Linda Fried include United States Department of Veterans Affairs & University of Rochester.
Papers
More filters
Journal ArticleDOI
Dietary Sodium/Potassium Intake Does Not Affect Cognitive Function or Brain Imaging Indices.
Kristen L. Nowak,Linda Fried,Anna Jovanovich,Anna Jovanovich,Joachim H. Ix,Kristine Yaffe,Zhiying You,Michel Chonchol +7 more
TL;DR: In community-dwelling older adults, higher sodium:potassium, but not sodium or potassium intake alone, was associated with decline in cognitive function, with no associations observed with micro- and macro-structural brain MRI indices.
Journal ArticleDOI
Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients.
TL;DR: Kt/V calculated using actual body weight less than 1.7 in anuric peritoneal dialysis patients is associated with increased mortality and hospitalization, and use of ideal body weight to calculate Kt/Vs weakened the associations with outcomes.
Journal ArticleDOI
Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults.
Jennifer N. Cooper,Linda Fried,Ping G. Tepper,Emma Barinas-Mitchell,Molly B. Conroy,Rhobert W. Evans,Maria M. Brooks,Genevieve A. Woodard,Kim Sutton-Tyrrell +8 more
TL;DR: Favorable changes in obesity-related factors are associated with reductions in ald testosterone in young adults with no risk factors besides excess weight, an important finding, given aldosterone’s emergence as an important cardiometabolic risk factor.
Journal ArticleDOI
Hemoglobin and Overt Nephropathy Complications in Type 1 Diabetes
TL;DR: HGB, even in the clinically normal range, is able to predict long-term complications in those with T1D and ON, particularly in those who do not develop ESRD.
RECOMMENDATIONS FOR THE TREATMENT OF LIPID DISORDERS IN PATIENTS ON PERITONEAL DIALYSIS ISPD Guidelines/Recommendations RECOMMENDATIONS FOR THE TREATMENT OF LIPID DISORDERS IN PATIENTS ON PERITONEAL DIALYSIS
TL;DR: In this paper, the authors show that lipid-lowering therapies may not have a significant effect on patients with ESRD compared to the general population, and the etiology of these abnormalities may be even more complex in the renal failure patient.